Paper42012184
Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response.
Singh S and 2 others. J Virol, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. Papers, record 42012184. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42012184
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| HIV-1 | Major topic |
| env Gene Products, Human Immunodeficiency Virus | Major topic |
| HIV Antibodies | Major topic |
| HIV Infections | Major topic |
| Antibodies, Neutralizing | Major topic |
| Humans | |
| Epitopes | |
| Animals | |
| Vaccine Development |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| BT/PR39156/DRUG/134/91/2021 | Department of Biotechnology, Ministry of Science and Technology, India | PubMed | ||
| BT/PR30120/MED/29/1339/2018 | Department of Biotechnology, Ministry of Science and Technology, India | PubMed |
Source PubMed
References166
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21715490 | Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. | J Virol | 2011 | https://conductscience.org/library/papers/21715490 | PubMed |
| 2 | 24590074 | Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. | Nature | 2014 | https://conductscience.org/library/papers/24590074 | PubMed |
| 3 | 36206752 | Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens. | Cell Rep Med | 2022 | https://conductscience.org/library/papers/36206752 | PubMed |
| 4 | 30190230 | When designing vaccines, consider the starting material: the human B cell repertoire. | Curr Opin Immunol | 2018 | https://conductscience.org/library/papers/30190230 | PubMed |
| 5 | 26088135 | A New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS. | J Biol Chem | 2015 | https://conductscience.org/library/papers/26088135 | PubMed |
| 6 | 32075877 | Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. | Science | 2020 | https://conductscience.org/library/papers/32075877 | PubMed |
| 7 | 32675574 | Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies. | Curr Opin HIV AIDS | 2020 | https://conductscience.org/library/papers/32675574 | PubMed |
| 8 | 20577269 | Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design. | Nat Rev Immunol | 2010 | https://conductscience.org/library/papers/20577269 | PubMed |
| 9 | 33563983 | Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles. | NPJ Vaccines | 2021 | https://conductscience.org/library/papers/33563983 | PubMed |
| 10 | 23539181 | Rational HIV immunogen design to target specific germline B cell receptors. | Science | 2013 | https://conductscience.org/library/papers/23539181 | PubMed |
| 11 | 28847869 | Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. | J Exp Med | 2017 | https://conductscience.org/library/papers/28847869 | PubMed |
| 12 | 24145402 | Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/24145402 | PubMed |
| 13 | 21762802 | HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. | J Mol Biol | 2011 | https://conductscience.org/library/papers/21762802 | PubMed |
| 14 | 27349805 | Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability. | Nat Commun | 2016 | https://conductscience.org/library/papers/27349805 | PubMed |
| 15 | 26372963 | Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26372963 | PubMed |
| 16 | 23824824 | Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein. | J Virol | 2013 | https://conductscience.org/library/papers/23824824 | PubMed |
| 17 | 40794027 | Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes. | J Exp Med | 2025 | https://conductscience.org/library/papers/40794027 | PubMed |
| 18 | 40388952 | Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa. | Lancet Microbe | 2025 | https://conductscience.org/library/papers/40388952 | PubMed |
| 19 | 40373112 | Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans. | Science | 2025 | https://conductscience.org/library/papers/40373112 | PubMed |
| 20 | 28978939 | Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity. | Sci Rep | 2017 | https://conductscience.org/library/papers/28978939 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42984752 | Immunogenicity and structure of a stabilized HIV-1 clade C Env from a pediatric elite neutralizer in complex with an autologous bnAb. | Front Immunol | 2026 | https://conductscience.org/library/papers/42984752 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ERVK-20 | 100616444 | PubTator's text mining | https://conductscience.org/library/genes/100616444 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42012184
GET https://conductscience.org/api/papers/v1/42012184/references?page=2